glutathion synthase ligase Glutamate cysteine and the age-related decline in cellular glutathione: The therapeutic potential of γ-glutamylcysteine Learn about potential problems with

Triple quadrupole versus high resolution quadrupole-time-of-flight mass spectrometry for quantitative LC-MS/MS analysis of 25-hydroxyvitamin D in human serum

FOXO4-DRI acts as a decoy that competes with FOXO4 for p53

It doesnt get out of your gut

Upcoming FDA Decisions fo r January 2026 Tividenofusp alfa (BLA), January 5 Denali Therapeutics For the treatment of Hunter syndrome

The treatment, which was previously indicated only for symptomatic children 3 years of age and older with late infantile CLN2 disease, also known as Batten disease, can now be given to diagnosed children of all ages, regardless of whether they are symptomatic or presymptomatic

These antibodies include anti-TfR1, anti-malondialdehyde adduct, and anti-4-hydroxynonenal (4HNE) antibodies (Feng et al., 2020)